BlackRock, Inc.

13F Holdings History for LIGAND PHARMACEUTICALS INC - Common Stock (LGND)

Symbol: LGND on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 2.95M shares
Security Ownership: 15.6%

Shares, Excluding Options vs Price

Value, Excluding Options

BlackRock, Inc. ownership in LIGAND PHARMACEUTICALS INC Common Stock (LGND)

2025-02-05 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.95M shares of LIGAND PHARMACEUTICALS INC Common Stock (LGND). This represents 15.6% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BlackRock, Inc.	15.6%		$306M	2.95M			$103.85	13G/A	12/31/2024	5 Feb 2025 13:23:34

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.01%	0%	$331M	2.91M	-6,494	-0.22%	$113.68	Q2 2025
3/31/2025	0.01%	0%	$307M	2.92M	-25,849		$105.14	Q1 2025
12/31/2024	0.01%	0%	$316M	2.95M	-53,548	-1.79%	$107.15	Q4 2024
9/30/2024	0.01%		$300M	3M			$100.09	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.